Activists urge Biden to champion temporary COVID-19 IP waiver

Medical and human rights groups have called on US President Joe Biden to step up his personal engagement and help put in place a temporary waiver of IP rights for COVID-19 vaccines.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Former world leaders call on Biden to waive COVID IPs

15 April 2021 A group of more than 170 former world leaders and Nobel Laureates has called upon US President Joe Biden to waive IP rights for COVID vaccines, in an open letter posted yesterday.

Big Pharma

Omicron variant delays COVID-19 IP waiver debate

29 November 2021 The World Trade Organization has postponed its ministerial conference indefinitely, potentially ending the opportunity for countries to agree an IP waiver for COVID-19 vaccines this year.

article

IP waiver won’t solve vaccine problems, warn experts

1 February 2022 A landmark proposal to suspend provisions of TRIPS for COVID-19 vaccines and treatments was first raised in October 2020. But, nearly a year and a half later, in January 2022, it seems there is no end in sight, with members of the World Trade Organization failing to reach consensus.

More on this story

Americas

Former world leaders call on Biden to waive COVID IPs

15 April 2021 A group of more than 170 former world leaders and Nobel Laureates has called upon US President Joe Biden to waive IP rights for COVID vaccines, in an open letter posted yesterday.

Big Pharma

Omicron variant delays COVID-19 IP waiver debate

article

IP waiver won’t solve vaccine problems, warn experts

More on this story

Americas

Former world leaders call on Biden to waive COVID IPs

15 April 2021 A group of more than 170 former world leaders and Nobel Laureates has called upon US President Joe Biden to waive IP rights for COVID vaccines, in an open letter posted yesterday.

Big Pharma

Omicron variant delays COVID-19 IP waiver debate

article

IP waiver won’t solve vaccine problems, warn experts